Evoke Pharma, Inc.
EVOKNASDAQHealthcare
$11.00
+$11.00(+0.00%)
Market Cap$18946499
P/E Ratio—
52W High$11
52W Low$1.94
Evoke Pharma, Inc.（EVOK）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EVOK · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $10.25M | $5.18M | $2.51M | $1.62M | $0.02M |
| Cost of Revenue | $0.36M | $0.20M | $0.37M | $0.33M | $0.09M |
| Gross Profit | $9.89M | $4.98M | $2.14M | $1.29M | ($0.06M) |
| Gross Margin %(computed) | 96.52% | 96.10% | 85.24% | 79.72% | -276.68% |
| Operating Expenses | |||||
| R&D Expenses | $0.02M | $0.18M | $0.30M | $0.59M | $6.55M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $15.10M | $12.41M | $9.92M | $9.44M | $12.98M |
| Operating Income | ($5.20M) | ($7.43M) | ($7.79M) | ($8.15M) | ($13.05M) |
| Operating Margin %(computed) | -50.77% | -143.44% | -310.37% | -503.79% | — |
| Interest Income | $0.35M | $0.14M | $0.06M | $0.01M | $0.01M |
| Interest Expense | $0.50M | $0.50M | $0.50M | $0.50M | $0.11M |
| Income Before Tax | ($5.35M) | ($7.79M) | ($8.22M) | ($8.54M) | ($13.15M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($5.35M) | ($7.79M) | ($8.22M) | ($8.54M) | ($13.15M) |
| Net Margin %(computed) | -52.22% | -150.41% | -327.83% | -527.66% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.81 | $-27.97 | $-31.16 | $-40.40 | $-74.91 |
| Wtd Avg Shares | 1.91M | 0.28M | 0.26M | 0.22M | 0.18M |
| EBITDA | $0.35M | ($7.15M) | ($7.72M) | ($8.04M) | ($13.04M) |
| EBITDA Margin %(computed) | 3.45% | -138.09% | -307.90% | -496.76% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Evoke Pharma, Inc.
关于Evoke Pharma, Inc.（EVOK）损益表
Evoke Pharma, Inc.（EVOK）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，EVOK实现营收$0.01B，毛利润$0.01B（毛利率96.52%），净利润($0.01B)（净利率-52.22%）。
常见问题
EVOK · 4 问Evoke Pharma, Inc.（EVOK）2024财年营收为$0.01B，同比up97.8%。
EVOK revenueEVOK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09